Showing results (171-180 of 192) with videos related to
Sort By:
Pageof 20
Archives of Surgery (Chicago, Ill. : 1960)|June 8, 2000
What prognostic factors are important in duodenal adenocarcinoma?F G Bakaeen, M M Murr, M G Sarr, et al.HPB : the Official Journal of the International Hepato Pancreato Biliary Association|November 21, 2014
Model to predict survival after surgical resection of intrahepatic cholangiocarcinoma: the Mayo Clinic experienceShahzad M Ali, Clancy J Clark, Taofic Mounajjed, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2008
Adjuvant radiotherapy and chemotherapy for pancreatic carcinoma: the Mayo Clinic experience (1975-2005)Michele M Corsini, Robert C Miller, Michael G Haddock, et al.Gastroenterology|January 29, 2008
Immunoglobulin G4-associated cholangitis: clinical profile and response to therapyAmaar Ghazale, Suresh T Chari, Lizhi Zhang, et al.The American Journal of Gastroenterology|August 10, 2007
Do consensus indications for resection in branch duct intraductal papillary mucinous neoplasm predict malignancy? A study of 147 patientsMario Pelaez-Luna, Suresh T Chari, Thomas C Smyrk, et al.Gastroenterology|April 1, 2010
Differences in clinical profile and relapse rate of type 1 versus type 2 autoimmune pancreatitisRaghuwansh P Sah, Suresh T Chari, Rahul Pannala, et al.Gastrointestinal Endoscopy|November 28, 2016
EUS-guided fine-needle injection of gemcitabine for locally advanced and metastatic pancreatic cancerMichael J Levy, Steven R Alberts, William R Bamlet, et al.Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|March 2, 2011
Patterns of pancreatic resection differ between patients with familial and sporadic pancreatic cancerJoshua G Barton, Thomas Schnelldorfer, Christine M Lohse, et al.Surgery|December 26, 2017
Implementation of prospective, surgeon-driven, risk-based pathway for pancreatoduodenectomy results in improved clinical outcomes and first year cost savings of $1 millionChristopher R Shubert, Michael L Kendrick, Elizabeth B Habermann, et al.Journal of Surgical Oncology|July 22, 2016
Implications of CA19-9 elevation for survival, staging, and treatment sequencing in intrahepatic cholangiocarcinoma: A national cohort analysisJohn R Bergquist, Tommy Ivanics, Curtis B Storlie, et al.Pageof 20